Page last updated: 2024-08-16

sulfadiazine and atovaquone

sulfadiazine has been researched along with atovaquone in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (37.04)	18.2507
2000's	12 (44.44)	29.6817
2010's	5 (18.52)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bibal, B; Bouammali, B; Cherkaoui, O; Fillion, H; Nebois, P; Pautet, F; Pétavy, AF; Sarciron, ME; Walchshofer, N	1
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Aubert, D; Bouldouyre, MA; Derouin, F; Garin, JF; Meneceur, P; Menotti, J; Sauvage, V; Villena, I	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Araujo, FG; Huskinson-Mark, J; Remington, JS	1
Winstanley, P	1
Cardenal, C; Gatell, JM; Guelar, A; Mallolas, J; Miró, JM; Soriano, E; Zamora, L	1
Araujo, FG; Remington, JS; Slifer, T	1
Derouin, F; Pudney, M; Romand, S	1
Araujo, FG; Lin, T; Remington, JS	1
Araujo, FG; Remington, JS; Suzuki, Y	1
Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F	1
Brettle, RP; Burns, SM; Flegg, PJ; Laing, RB; Leen, CL	1
Araujo, FG; Bryskier, A; Khan, AA; Remington, JS	1
Lakritz, J; Marsh, AE; Mullins, AL	1
Borner, K; Hahn, H; Kayser, O; Krause, K; Liesenfeld, O; Müller, RH; Schöler, N	1
Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL	1
Arasteh, K; Borner, K; Bushrab, FN; Dunay, IR; Fitzner, R; Heimesaat, MM; Kurowski, M; Liesenfeld, O; Müller, RH; Stocker, H	1
Alves, CF; Vitor, RW	1
Androudi, S; Bhaila, I; Fiore, T; Iaccheri, B; Janjua, S; Papadaki, T; Stephen Foster, C	1
de Almeida Vitor, RW; de Oliveira, AB; Ferreira, RA; Fujiwara, RT; Gazzinelli Guimarães, PH; Gualberto, SA; Miguel Del Corral, JM	1
Davis, LA; Davis, PH; Judge, AK; Larson, JJ; Neville, AJ; Vennerstrom, JL; Wang, X; Zach, SJ	1
Bejjanki, H; Koratala, A; Olaoye, OA; Santos, AH	1

Reviews

2 review(s) available for sulfadiazine and atovaquone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Antipsychotic Agents; Atovaquone; Clindamycin; Drug Repositioning; Humans; Macrolides; Parasitic Sensitivity Tests; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis	2015

Trials

2 trial(s) available for sulfadiazine and atovaquone

Article	Year
Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. AIDS (London, England), 1996, Volume: 10, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Atovaquone; Clindamycin; Encephalitis; Female; Humans; Male; Naphthoquinones; Pyrimethamine; Recurrence; Risk Factors; Sulfadiazine; Survival Analysis; Time Factors; Toxoplasmosis, Cerebral	1996
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, May-01, Volume: 34, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Atovaquone; Drug Therapy, Combination; Encephalitis; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Time Factors; Toxoplasma; Treatment Outcome	2002

Article

Year

Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.

AIDS (London, England), 1996, Volume: 10, Issue:10

Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Atovaquone; Clindamycin; Encephalitis; Female; Humans; Male; Naphthoquinones; Pyrimethamine; Recurrence; Risk Factors; Sulfadiazine; Survival Analysis; Time Factors; Toxoplasmosis, Cerebral

1996

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, May-01, Volume: 34, Issue:9

Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Atovaquone; Drug Therapy, Combination; Encephalitis; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Time Factors; Toxoplasma; Treatment Outcome

2002

Other Studies

23 other study(ies) available for sulfadiazine and atovaquone

Article	Year
Quinonic derivatives active against a virulent strain of Toxoplasma gondii. Synthesis of 2-methylfuro[2,3-g]- and [3,2-g]isoquinolinetriones. Bioorganic & medicinal chemistry letters, 2000, May-01, Volume: 10, Issue:9 Topics: Animals; Antiprotozoal Agents; Cell Line; Furans; Humans; Monocytes; Quinolines; Toxoplasma	2000
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Animals; Antiprotozoal Agents; Atovaquone; Genotype; Humans; Inhibitory Concentration 50; Parasitic Sensitivity Tests; Pyrimethamine; Sulfadiazine; Toxoplasma	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. The Journal of infectious diseases, 1991, Volume: 164, Issue:1 Topics: Adenine; Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Brain; Clindamycin; Coccidiostats; Erythromycin; Fluorouracil; Mice; Mice, Inbred CBA; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma	1991
Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome. Postgraduate medical journal, 1995, Volume: 71, Issue:837 Topics: AIDS-Related Opportunistic Infections; Atovaquone; Clindamycin; Coccidiostats; Humans; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Cerebral	1995
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]. Enfermedades infecciosas y microbiologia clinica, 1994, Volume: 12, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Atovaquone; Clarithromycin; Clindamycin; Drug Therapy, Combination; Folic Acid; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Cerebral	1994
Rifabutin is active in murine models of toxoplasmosis. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:3 Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Clindamycin; Drug Therapy, Combination; Female; Mice; Mice, Inbred CBA; Naphthoquinones; Pyrimethamine; Rifabutin; Sulfadiazine; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral	1994
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:11 Topics: Animals; Antiprotozoal Agents; Atovaquone; Clarithromycin; Coccidiostats; Drug Combinations; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Kinetics; Mice; Minocycline; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal	1993
The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine. The Journal of infectious diseases, 1993, Volume: 167, Issue:2 Topics: Animals; Antiprotozoal Agents; Atovaquone; Drug Synergism; Drug Therapy, Combination; Female; Mice; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Animal	1993
Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:5 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; Brain; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Encephalitis; Female; Mice; Mice, Inbred CBA; Naphthoquinones; Pyrimethamine; Rifabutin; Sulfadiazine; Toxoplasmosis, Cerebral; Treatment Outcome	1996
Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atovaquone; Autopsy; Azithromycin; Brain; CD4 Lymphocyte Count; Clindamycin; Drug Therapy, Combination; Female; Humans; Incidence; Lymphoma, AIDS-Related; Male; Middle Aged; Naphthoquinones; Pyrimethamine; Retrospective Studies; Sulfadiazine; Toxoplasmosis, Cerebral; United Kingdom	1996
Use of ketolides in combination with other drugs to treat experimental toxoplasmosis. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:5 Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Atovaquone; Clindamycin; Drug Therapy, Combination; Female; Ketolides; Macrolides; Mice; Naphthoquinones; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal	1998
In vitro quantitative analysis of (3)H-uracil incorporation by Sarcocytis neurona to determine efficacy of anti-protozoal agents. Veterinary parasitology, 2001, Feb-26, Volume: 95, Issue:2-4 Topics: Animals; Antiprotozoal Agents; Atovaquone; Cattle; Deer; DNA Replication; Glycine; Glyphosate; Herbicides; Male; Naphthoquinones; Nitriles; Pyrimethamine; Reproduction; Sarcocystis; Sulfadiazine; Sulfamethoxazole; Tetracycline; Triazines; Tritium; Uracil	2001
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:6 Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Chromatography, High Pressure Liquid; Injections, Intravenous; Macrophages, Peritoneal; Male; Mice; Naphthoquinones; Sulfadiazine; Suspensions; Tissue Distribution; Toxoplasma; Toxoplasmosis, Animal	2001
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Female; Injections, Intravenous; Liver; Lung; Mass Spectrometry; Meninges; Mice; Mice, Inbred C57BL; Naphthoquinones; Pyrimethamine; Sulfadiazine; Survival Analysis; Toxoplasmosis, Cerebral	2004
Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil. Parasite (Paris, France), 2005, Volume: 12, Issue:2 Topics: Animals; Antiprotozoal Agents; Atovaquone; Coccidiostats; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Female; Genotype; Mice; Naphthoquinones; Random Allocation; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal; Treatment Outcome	2005
Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review. Clinical therapeutics, 2008, Volume: 30, Issue:11 Topics: Adolescent; Adult; Atovaquone; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; Gastrointestinal Diseases; Humans; Male; Medical Records; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis, Ocular; Trimethoprim; Vitreous Body; Young Adult	2008
New naphthoquinones and an alkaloid with in vitro activity against Toxoplasma gondii RH and EGS strains. Experimental parasitology, 2012, Volume: 132, Issue:4 Topics: Animals; Antimalarials; Aporphines; Atovaquone; Cells, Cultured; Coccidiostats; Female; Fibroblasts; Foreskin; Humans; Inhibitory Concentration 50; Male; Mice; Naphthoquinones; Structure-Activity Relationship; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal	2012
Liver transplant, toxoplasmosis and kidney stones: connecting the dots. BMJ case reports, 2019, Feb-15, Volume: 12, Issue:2 Topics: Aftercare; Antimalarials; Antiprotozoal Agents; Atovaquone; Brain; Brain Edema; Female; Humans; Kidney Calculi; Liver Transplantation; Magnetic Resonance Imaging; Middle Aged; Pentamidine; Pneumonia, Pneumocystis; Sulfadiazine; Toxoplasmosis, Cerebral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Ultrasonography	2019